HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ki26894

a transforming growth factor-beta type I receptor kinase inhibitor that inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line
Networked: 4 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Shimizu, Kiyoshi: 3 articles (08/2012 - 01/2007)
2. Shimizu, Toshiyuki: 3 articles (08/2012 - 01/2007)
3. Tsuchida, Kunihiro: 1 article (08/2012)
4. Murakami, Tatsufumi: 1 article (08/2012)
5. Sunada, Yoshihide: 1 article (08/2012)
6. Ishizaki, Masatoshi: 1 article (08/2012)
7. Nishimatsu, Shin-Ichiro: 1 article (08/2012)
8. Okada, Tadashi: 1 article (08/2012)
9. Suga, Tomohiro: 1 article (08/2012)
10. Hinohara, Atsushi: 1 article (08/2012)

Related Diseases

1. Muscular Atrophy (Muscle Atrophy)
2. Neoplasm Metastasis (Metastasis)
3. Stomach Neoplasms (Stomach Cancer)
4. Breast Neoplasms (Breast Cancer)
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. TGF-beta type I receptor
2. Transforming Growth Factor beta Receptors (TGF beta Receptors)
3. Transforming Growth Factor beta (TGF-beta)
4. Transforming Growth Factor beta1 (TGF beta 1)
5. Cadherins (E-Cadherin)
6. Phosphotransferases (Kinase)
7. Myosins (Myosin)
8. Adenosine Triphosphate (ATP)
9. 1-(2-chloroethyl)-1-nitrosourea (CNU)

Related Therapies and Procedures

1. Oral Administration